ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for tools Level up your trading with our powerful tools and real-time insights all in one place.

RVMD Revolution Medicines Inc

40.90
1.71 (4.36%)
May 03 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Stock Type
Revolution Medicines Inc RVMD NASDAQ Common Stock
  Price Change Price Change % Share Price Last Trade
1.71 4.36% 40.90 19:00:00
Open Price Low Price High Price Close Price Previous Close
40.00 39.10 40.21 40.20 39.19
more quote information »

Recent News

Date Time Source Heading
5/01/202415:05GLOBERevolution Medicines to Report Financial Results for First..
4/09/202414:34GLOBERevolution Medicines Announces Publication on the Discovery..
4/08/202410:36GLOBERevolution Medicines Announces Publications on the Discovery..
4/04/202415:05GLOBERevolution Medicines to Participate in Upcoming Investor..
3/28/202415:05GLOBERevolution Medicines to Deliver Multiple Presentations at..
3/05/202415:54EDGAR2Form 4 - Statement of changes in beneficial ownership of..
3/05/202415:53EDGAR2Form 4 - Statement of changes in beneficial ownership of..
3/05/202415:52EDGAR2Form 4 - Statement of changes in beneficial ownership of..
3/04/202416:23EDGAR2Form S-3ASR - Automatic shelf registration statement of..
2/26/202416:04EDGAR2Form S-8 - Securities to be offered to employees in employee..
2/26/202415:05GLOBERevolution Medicines Reports Fourth Quarter and Full Year..
2/26/202415:04EDGAR2Form 8-K - Current report
2/20/202415:05GLOBERevolution Medicines to Report Financial Results for Fourth..
2/09/202416:22EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
2/01/202415:05GLOBERevolution Medicines to Participate in Upcoming Investor..
1/24/202415:12EDGAR2Form 4 - Statement of changes in beneficial ownership of..
1/22/202415:18EDGAR2Form 144 - Report of proposed sale of securities
1/09/202413:15EDGAR2Form 8-K - Current report
1/04/202406:00GLOBERevolution Medicines to Present at 42nd Annual J.P...
12/20/202316:10EDGAR2Form 4 - Statement of changes in beneficial ownership of..
12/20/202316:08EDGAR2Form 4 - Statement of changes in beneficial ownership of..
12/14/202317:22EDGAR2Form 144 - Report of proposed sale of securities
12/14/202316:48EDGAR2Form 144 - Report of proposed sale of securities
11/20/202317:24EDGAR2Form 4 - Statement of changes in beneficial ownership of..
11/20/202315:14EDGAR2Form 144 - Report of proposed sale of securities
11/16/202313:58EDGAR2Form CERT - Certification by an exchange approving..
11/15/202315:04EDGAR2Form 8-A12B - Registration of securities [Section 12(b)]
11/14/202319:15EDGAR2Form 4 - Statement of changes in beneficial ownership of..
11/14/202319:13EDGAR2Form 4 - Statement of changes in beneficial ownership of..
11/14/202319:13EDGAR2Form 3 - Initial statement of beneficial ownership of..
11/09/202308:20EDGAR2Form 8-K - Current report
11/09/202308:10GLOBERevolution Medicines Completes Acquisition of EQRx
11/08/202310:30GLOBERevolution Medicines and EQRx Stockholders Approve EQRx..
11/06/202315:09EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
11/06/202315:05GLOBERevolution Medicines Reports Third Quarter 2023 Financial..
11/06/202315:05EDGAR2Form 8-K - Current report
11/01/202306:15EDGAR2Form DEFA14A - Additional definitive proxy soliciting..
11/01/202306:11EDGAR2Form 425 - Prospectuses and communications, business..
11/01/202306:08EDGAR2Form 8-K - Current report
11/01/202306:00GLOBELeading Independent Proxy Advisory Firms ISS and Glass Lewis..
10/31/202315:15GLOBERevolution Medicines to Report Financial Results for Third..
10/23/202317:01EDGAR2Form 4 - Statement of changes in beneficial ownership of..
10/23/202305:13EDGAR2Form 425 - Prospectuses and communications, business..
10/23/202305:11EDGAR2Form 8-K - Current report
10/22/202301:30GLOBERevolution Medicines Presents Promising Clinical Activity..
10/13/202310:54EDGAR2Form 8-K - Current report
10/13/202310:50GLOBERevolution Medicines Presents Encouraging Clinical Data for..
10/04/202315:05GLOBERevolution Medicines to Present New Clinical Data at Major..
10/02/202315:12EDGAR2Form 4 - Statement of changes in beneficial ownership of..
9/29/202315:19EDGAR2Form DEFM14A - Definitive proxy statement relating to merger..

Your Recent History

Delayed Upgrade Clock